🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/04/2022 | 63,37 | 64,61 | 62,80 | 64,37 | +2,46% | 2,85% | 157.896 |
| 18/04/2022 | 65,50 | 65,50 | 62,39 | 62,82 | -4,33% | 4,75% | 230.672 |
| 14/04/2022 | 68,44 | 68,44 | 65,51 | 65,66 | -4,18% | 4,27% | 126.637 |
| 13/04/2022 | 65,91 | 68,87 | 65,91 | 68,53 | +4,40% | 4,49% | 222.657 |
| 12/04/2022 | 66,68 | 68,14 | 65,07 | 65,64 | -0,62% | 4,60% | 197.971 |
| 11/04/2022 | 66,45 | 68,23 | 65,88 | 66,05 | -1,94% | 3,55% | 203.421 |
| 08/04/2022 | 69,37 | 70,22 | 67,12 | 67,36 | -3,28% | 4,48% | 277.479 |
| 07/04/2022 | 70,79 | 71,57 | 69,46 | 69,64 | -2,06% | 2,97% | 235.641 |
| 06/04/2022 | 69,05 | 72,05 | 68,43 | 71,11 | +1,82% | 5,23% | 305.852 |
| 05/04/2022 | 72,81 | 73,03 | 69,83 | 69,84 | -3,70% | 4,39% | 314.348 |
| 04/04/2022 | 73,58 | 73,85 | 71,75 | 72,52 | -0,69% | 2,85% | 364.683 |
| 01/04/2022 | 71,05 | 73,18 | 71,05 | 73,03 | +4,06% | 2,99% | 329.577 |
| 31/03/2022 | 72,78 | 73,45 | 69,97 | 70,17 | -3,17% | 4,78% | 320.921 |
| 30/03/2022 | 75,02 | 75,90 | 72,36 | 72,47 | -3,83% | 4,71% | 174.406 |
| 29/03/2022 | 72,42 | 75,62 | 72,40 | 75,36 | +5,38% | 4,44% | 344.324 |
| 28/03/2022 | 71,01 | 72,45 | 70,03 | 71,51 | +0,23% | 3,41% | 169.597 |
| 25/03/2022 | 72,06 | 72,06 | 70,78 | 71,35 | -0,80% | 1,77% | 129.843 |
| 24/03/2022 | 69,17 | 72,31 | 68,78 | 71,92 | +4,97% | 5,11% | 191.559 |
| 23/03/2022 | 70,16 | 70,62 | 68,42 | 68,52 | -3,19% | 3,15% | 144.110 |
| 22/03/2022 | 70,26 | 71,51 | 69,89 | 70,77 | +0,60% | 2,31% | 158.216 |
| 21/03/2022 | 69,58 | 70,61 | 67,40 | 70,35 | +0,74% | 4,62% | 261.129 |
| 18/03/2022 | 67,33 | 69,85 | 67,33 | 69,83 | +2,34% | 3,74% | 488.755 |
| 17/03/2022 | 66,90 | 69,26 | 66,29 | 68,23 | +0,81% | 4,43% | 169.597 |
| 16/03/2022 | 65,68 | 67,69 | 65,01 | 67,69 | +3,80% | 4,07% | 153.247 |
| 15/03/2022 | 63,41 | 65,28 | 62,66 | 65,21 | +3,15% | 4,12% | 199.574 |
| 14/03/2022 | 65,05 | 67,10 | 62,57 | 63,22 | -1,66% | 6,96% | 235.320 |
| 11/03/2022 | 68,19 | 69,30 | 64,27 | 64,29 | -4,68% | 7,36% | 478.816 |
| 10/03/2022 | 64,42 | 67,66 | 64,19 | 67,44 | +2,56% | 5,39% | 200.215 |
| 09/03/2022 | 62,74 | 66,23 | 62,74 | 65,76 | +5,88% | 5,55% | 330.058 |
| 08/03/2022 | 61,29 | 64,25 | 60,66 | 62,11 | +1,69% | 5,85% | 255.999 |